Media Summary: Dr. Larry Goldenberg, Professor & Head, Department of Urologic Sciences, and Director of Development, the Vancouver Join Dr. Art Rastinehad in this enlightening session tailored for patients facing unfavorable Description: Uncover the nuances of favorable
Understanding Prostate Cancer Intermediate Risk - Detailed Analysis & Overview
Dr. Larry Goldenberg, Professor & Head, Department of Urologic Sciences, and Director of Development, the Vancouver Join Dr. Art Rastinehad in this enlightening session tailored for patients facing unfavorable Description: Uncover the nuances of favorable PCRI's Executive Director, Mark Scholz, MD, compares different treatments for men with Teal stage ( ... he discusses the challenges in treatment planning for patients with Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for
Filmed in February 2020 Backed by extensive clinical evidence, the Decipher® David T. Marshall, M.D., is a board-certified radiation oncologist, specializing in genitourinary and gastrointestinal Filmed in March 2020 Backed by extensive clinical evidence, the Decipher®
